Clinical utility of a tumor-naïve circulating tumor DNA (ctDNA) test to predict outcomes in patients with advanced testicular germ cell tumors. Treatment of poor-risk non seminomatous germ-cell tumors ...

Background: Since 2014, adaptation of chemotherapy based on tumor marker decline after the cycle of BEP (Bleomycin, Etoposide, Cisplatin) is a standard for patients with IGCCCG poor-risk NSGCT based ...

Organ-specific Markers in Circulating Tumor Cell Screening An Early Indicator of Metastasis-Capable Malignancy. Patrizia Paterlini-Bréchot. Disclosures. Future Oncol. 2011;7(7):849-871. ...

A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free immunotherapy treatment in cancer patients.

Scientists discover how cells absorb queuosine, a vital nutrient affecting memory, learning, and cancer resistance.

Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 is a postinfectious condition identified during the COVID-19 pandemic with specific Centers for Disease Control and ...

Someone with a brain tumor can experience the following symptoms: Persistent headaches, seizures, cognitive or speech difficulties, personality changes, weakness or numbness on one side of the ...

Combination treatment reduces risk of tumor progression in aggressive form of breast cancer, study shows. Use of Gilead’s Trodelvy, Merck’s Keytruda together could change practice, experts say ...